Vunakizumab ELISA Kit (GXEL00223)

(No reviews yet) Write a Review

SKU:
GXEL00223
Product Type:
ELISA Kit
Assay Type:
Quantitative
Detection Method:
Colorimetric
Sensitivity:
0.156 μg/ml
Range:
0.31-5 μg/mL
Size:
96T
Synonyms:
SHR-1314, 1792181-33-9
€0.00
Frequently bought together:

Description

Vunakizumab ELISA Kit

The Vunakizumab ELISA Kit (SKU: GXEL00223) enables sensitive, reproducible quantitative detection of Vunakizumab in Plasma, Serum using a quantitative ELISA format. The assay delivers a detection range of 0.31-5 μg/mL and a sensitivity of 0.156 μg/ml and is read colorimetrically at 450 nm, making it well suited to quantitative research workflows.

Vunakizumab is a recombinant humanized IgGκ monoclonal antibody binds to and neutralises the proinflammatory cytokine interleukin-17A (IL-17A). It was discovered and developed by Jiangsu Hengrui Medicine (China) with the developmental name SHR-1314, for the treatment of autoimmune diseases such as psoriasis, psoriatic arthritis, ankylosing spondylitis, multiple sclerosis and inflammatory arthritis. Atridia Pty. Ltd., which is now a part of Jiangsu Hengrui Medicine, start a phase-I clinical trial in psoriasis (in volunteers) in Australia in August 2016. Atridia completed the phase-I trial in July 2017. A phase-I/II study, which is started from December 2017, is ongoing to assess the safety, tolerability, and pharmacokinetics of SHR-1314 with expanded dose finding in subjects with moderate-to-severe plaque psoriasis.

Supplied with pre-coated microplates and all core reagents, the Vunakizumab ELISA Kit gives you a validated, ready-to-use solution for Vunakizumab research. Get accurate and reliable results with the Vunakizumab ELISA Kit from Assay Genie.

View AllClose